<DOC>
	<DOC>NCT00909051</DOC>
	<brief_summary>Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in a large sample of patients.</brief_summary>
	<brief_title>GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Patients with untreated or pretreated diabetes mellitus or patients for which acarbose is indicated and without acarbose treatment within the last three months before study inclusion. The decision for treatment type and duration is taken by the investigator and is made before inclusion into the study. Exclusion criteria must be read in conjunction with the local product information.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Diabetes Mellitus</keyword>
</DOC>